Gating charges per channel of Ca(V)2.2 channels are modified by G protein activation in rat sympathetic neurons

Arch Biochem Biophys. 2009 Jun 1;486(1):51-7. doi: 10.1016/j.abb.2009.04.002. Epub 2009 Apr 11.

Abstract

It has been suggested that voltage-dependent G protein modulation of Ca(V)2.2 channels is carried out at closed states of the channel. Our purpose was to estimate the number of gating charges of Ca(V)2.2 channel in control and G protein-modulated conditions. By using a Cole-Moore protocol we observed a significant delay in Ca(V)2.2 channel activation according to a transit of the channel through a series of closed states before channel opening. If G protein voltage-dependent modulation were carried out at these closed states, then we would have expected a greater Cole-Moore lag in the presence of a neurotransmitter. This prediction was confirmed for noradrenaline, while no change was observed in the presence of angiotensin II, a voltage-insensitive G protein modulator. We used the limiting slope method for calculation of the gating charge per channel. Effective charge z was 6.32+/-0.65 for Ca(V)2.2 channels in unregulated conditions, while GTPgammaS reduced elementary charge by approximately 4 e(0). Accordingly, increased concentration of noradrenaline induced a gradual decrease on z, indicating that this decrement was due to a G protein voltage-sensitive modulation. This paper shows for the first time a significant and reversible decrease in charge transfer of Ca(V)2.2 channels under G protein modulation, which might depend on the activated G protein inhibitory pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biophysical Phenomena
  • Calcium Channels, N-Type / metabolism*
  • GTP-Binding Proteins / metabolism*
  • Guanosine Diphosphate / analogs & derivatives
  • Guanosine Diphosphate / metabolism
  • Guanosine Diphosphate / pharmacology
  • In Vitro Techniques
  • Ion Channel Gating / drug effects
  • Male
  • Membrane Potentials / drug effects
  • Models, Neurological
  • Neurons / drug effects
  • Neurons / metabolism*
  • Norepinephrine / metabolism
  • Norepinephrine / pharmacology
  • Patch-Clamp Techniques
  • Rats
  • Rats, Wistar
  • Superior Cervical Ganglion / cytology
  • Superior Cervical Ganglion / drug effects
  • Superior Cervical Ganglion / metabolism*
  • Thionucleotides / metabolism
  • Thionucleotides / pharmacology

Substances

  • Cacna1b protein, rat
  • Calcium Channels, N-Type
  • Thionucleotides
  • Guanosine Diphosphate
  • guanosine 5'-O-(2-thiodiphosphate)
  • GTP-Binding Proteins
  • Norepinephrine